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ABSTRACT
Enhancing Microbiome Host Disease Prediction with Variational Autoencoders
by Celeste A. Manughian-Peter

Advancements in genetic sequencing methods for microbiomes in recent decades
have permitted the collection of taxonomic and functional profiles of microbial communities,
accelerating the discovery of the functional aspects of the microbiome and generating an
increased interest among clinicians in applying these techniques with patients. This advancement
has coincided with software and hardware improvements in the field of machine learning and
deep learning. Combined, these advancements implicate further potential for progress in disease
diagnosis and treatment in humans. The ability to classify a human microbiome profile into a
disease category, and additionally identify the differentiating factors within the profile between
diseased and healthy individuals are valuable missions for both disease diagnosis and
understanding the pathology. This can be particularly important in diseases with unknown
etiology, providing potential to develop and offer accurate diagnostic tools to clinicians who
currently diagnose based on the limited research available or as a diagnosis of exclusion.

Human microbiome studies like the Human Microbiome Project generate data that can help
produce important findings related to health care and disease diagnosis and treatment. The nature
of this data produces a large feature space relative to the number of samples and high sparsity,
which can make it challenging to use in machine learning models, especially when the number of
samples is small and much smaller than the number of features. Here, the IBD microbiome profiles
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from the Human Microbiome Project are used to classify disease. We show the use of
dimensionality reduction and variational autoencoders (VAE) in generating synthetic microbiome
profiles as a potential method to deal with this issue and increase existing disease classification
model performance. Results are compared across various baseline machine learning models with
traditional supervised and unsupervised dimensionality reduction techniques. We show that using
a dataset supplemented with VAE-generated artificial microbiome data improves classification
results for small datasets with large feature space compared to sample size, and highly imbalanced
class sizes, and may be used as a method to increase classification accuracy in microbiome-based
diagnostic tools.
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1 Introduction
Advancements made in genetic sequencing in recent decades have provided the
means to collect taxonomic profiles of microbial communities within the human body, called the
microbiome. Recent studies have proven these profiles to be a valuable asset in understanding,
predicting, and diagnosing diseases. Although many of the microorganisms in the microbiome
are essential in regulating our health and the immune system, alterations in relative abundance of
species in these profiles have been linked to the pathogenesis and dysfunction in numerous
diseases such as Inflammatory Bowel Disease (IBD), diabetes, cancer, chronic pain, depression,
neurodegenerative diseases and others with unknown etiology [1] [2] [3] [4] [5] [6]. Many
studies have been performed to characterize the differences in microbiomes across healthy and
diseased individuals [7] [8] [9]. Several open-source data sets for microbiome profiles exist that
document the microbiome profiles for both healthy and diseased patients. One such data source,
the Integrated Human Microbiome Project, has provided a repository of human microbiome
datasets associated with pregnancy, IBD, and Type 2 diabetes [10]. With the increasing
prevalence of these data sets, our understanding of the link between the human microbiome and
disease is growing and the ability to utilize these datasets for accurate diagnostics is becoming
more feasible [6] [11].

Despite this increased availability of biological data, hardware, and machine learning
libraries, research in many diseases, such as IBD, has not made a large impact on improving
patients’ quality of life. IBD is a gut-related condition involving chronic inflammation of the
digestive tract that burdens people with debilitating symptoms, leading to a lower quality of life.
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There is no definitive test for diagnosis of IBD or the two subtypes – Crohn’s disease and ulcerative
colitis. Thus, leveraging the microbiome profiles of IBD patients for use in machine and deep
learning models, and ultimately as a diagnostic tool, can aid in diagnostics and lead to quicker time
to treatment.
Leveraging public microbiome profiles for use in machine learning and deep learning
models has been facilitated not only by the prevalence of open-source microbiome data, but by
improvements in available computing hardware, deep learning software, and progress in both the
practical applicability and performance of deep learning models. Recently, various studies have
been performed that demonstrate the success in applying machine and deep learning to host trait
prediction via microbiome classification models. For example, Hacilar et al showed the use of
machine learning and feature selection techniques with IBD microbiome profiles to assess the
prediction performance on various machine learning models such as AdaBoost, Decision Tree,
LogitBoost, Random Forest and KNN with LogitBoost, achieving a highest accuracy of 86.9%
and highest ROC AUC of 92.6% with the KNN plus LogitBoost model [12]. Similarly, in another
study Xu et al used data from IBD gut microbiota samples to develop classifiers with Logistic
regression, Random Forest, Gradient Boosting, SVM, and LightGBM. LightGBM gave the best
performance with the highest average binary classification accuracy of 95.5% and ROC AUC of
96.4% [13]. More recently, Chieh Lo compared various models such as SVM, RF, and neural
networks with a custom statistical data augmentation approach [14]. A negative binomial
distribution was used to model and generate synthetic microbiome profiles and augmented the
original dataset to perform a variety of microbiome classification tasks, including classifying the
HMP IBD dataset. They achieved a highest classification score of .84 F1-micro and .78 F1-macro
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in multiclass classification of 1,321 IBD microbiome profiles using MLP classifier with
augmented data and dropout regularization [15].
However, the development of highly accurate predictive machine learning models to
classify a disease or its subtype from microbiome profiles can be made challenging when using
datasets that are high dimensional in nature and whose feature size is much larger than the sample
size [7]. Microbiome data typically contain feature sizes in the hundreds or thousands and have
the added issue of being sparse. Due to the commonly small sample size, large number of taxa in
the feature space compared to the sample size and the sparsity of the data, microbiome data has
the potential to fall prey to the curse of dimensionality. That is, various difficulties may arise during
exploratory analysis, dimensionality reduction, model training, or data visualization. To help
mitigate these issues, we apply dimensionality reduction techniques to reduce the feature space
and explore the use of developing variational autoencoders to generate artificial microbiome
profiles. This allows us to effectively increase the sample size and reduce the feature space.
Here, we use the microbiome profile data from the iHMP to train various machine learning
models to classify inflammatory bowel disease (IBD) and its subtypes, ulcerative colitis and
Crohn’s disease. Baseline machine learning models of random forest, adaptive boosting, bagging,
Light Gradient Boosting Machine, K-Nearest Neighbors, SVM, Decision Tree, and multilayer
perceptron were trained on the microbiome profiles to predict patient's disease status as non-IBD,
ulcerative colitis, or Crohn’s. Principal component analysis (PCA) and linear discriminant analysis
(LDA) are used to as dimensionality reduction techniques on the microbiome data. Performance
across baseline models is compared while using original microbiome profiles as input and the
PCA-reduced and LDA-reduced dimension profiles to demonstrate the effects of traditional
dimensionality reduction techniques when used with microbiome profiles. We then develop and
3

explore the architectures of two variational autoencoders, VAE and β-VAE. Both VAEs are trained
on the IBD microbiome profiles to generate synthetic data. The baseline machine learning models
trained on the original microbiome profiles, their reduced versions, and with the VAE-augmented
data set are compared.
Results demonstrate the potential value in using variational autoencoders combined with
traditional machine learning techniques to augment and classify the microbiome profile dataset,
increasing classification accuracy. Increased classification performance implicates further value in
using microbiome-based classifiers as a clinical diagnostic tool for diseases with unknown etiology
and limited or exclusion-based diagnostic procedures like inflammatory bowel disease. Thus,
developing high-accuracy multiclass classification models that distinguish healthy from unhealthy
microbiomes can aid in the diagnosis of microbiome-related diseases and could potentially provide
new means to prevent disease onset or to improve prognosis.

4

2

Data

This section details the original project that facilitated the collection and aggregation of
various microbiome profiles and associated metadata and made them available for public use. It
also gives context on the meaning, format, and characteristics of the human microbiome profiles
themselves. Summary statistics about the data and the class distribution in the original data, and
an overview of the disease to which these samples are classified are also provided.

2.1 The Integrative Human Microbiome Project

The data used for this project is downloaded from the Data Coordination Center (DCC) for
the Integrative Human Microbiome Project (iHMP), which was supported by the National
Institutes of Health (NIH) Common Fund. The goal of the HMP is to develop resources that
“facilitate the characterization of the human microbiota to further our understanding of how the
microbiome impacts human health and disease” [10]. The iHMP developed datasets of microbiome
profiles from cohort studies from three microbiome-related conditions. They established new
computational tools and biological perspectives of microbial activity during dysbiosis and gave
new opportunities for collaborating on microbiome research and relevant data integration.
According to the iHMP project page, the “site provides a common repository for diverse
human microbiome datasets and minimum reporting standards established by the DCC, from both
the initial HMP-1 phase and iHMP, providing researchers with the ability to query and retrieve
metagenomic, metatranscriptomic, human genetic, microbial culture, and many other data types
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from each project.” [10] We use the combined taxonomic microbiome profile dataset from the IBD
cohort study and related metadata for the analysis in this report.

2.2 Microbiome Taxonomy Data

The data used in this analysis are called taxonomic profiles. Taxonomic profiling gives us
insight into the composition of each patient’s sample. This type of analysis both identifies the
taxa present in a sample and estimates the relative abundances of organisms. Each microbiome
taxonomic profile contains a list of detected taxa and their estimated relative abundances. This
sample-by-taxon abundance matrix is a common data structure in biological analysis studies
[16]. In our case, we have 933 detected taxa, and a sparse matrix containing measures of their
relative abundance for each patient.
For the method of taxonomic profiling used to produce this data, reads are clustered
based on their similarity to Operational Taxonomic Units (OTUs). That is, using a database of
known marker genes, the taxa can be assigned to the reads depending on the sequence similarity
to an OTU. Each feature in this data set is then an OTU. A portion of the raw taxonomic
microbiome profiles used for this report are shown in Figure 1.

6

Figure 1. Raw taxonomic iHMP IBD microbiome profiles show the relative abundance of
bacteria species (row) in each of the 1638 patients (column).

2.3 IBD Microbiome Data Source
The dataset was downloaded from the Human Microbiome Project [10]. As mentioned, it
contains the relative abundances of microorganisms present in each patient's gut. The associated
metadata contains the patients' IBD diagnosis and other potentially important metadata. Recall
that IBD is a gut related disorder that involves chronic inflammation of the digestive tract. It
contains two subtypes, Crohn’s disease (CD) and ulcerative colitis (UC).
The dataset contains 1638 patient microbiome profiles and associated metadata, one
being the patient diagnosis. Each taxonomic profile contains 933 columns indicating the relative
abundance of organisms in the sample. The diagnoses are split into three categories, CD, UC,
and healthy non-IBD. The distribution of diagnoses across the dataset is uneven, as shown below
in Figure 2. Simple preprocessing allowed us to merge the microbiome taxonomic profiles with
the patient metadata, the diagnosis (Figure 3), and use this for the classification models.

7

Figure 2. The distribution of diagnoses among patients in the IBD microbiome profile dataset form
Human Microbiome Project shows a high number of patients with Crohn’s disease, and lower
amounts of patients with ulcerative colitis and healthy (non-IBD) diagnoses.

Figure 3. Merged microbiome profile and metadata datasets show the relative abundance
of bacteria for each patient and the patient diagnosis with a unique identifier now marking
the patient across the data.
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3 Methods
The methods outlined in this section detail the technique used for dimensionality reduction,
multiclass classification, data preprocessing, and data augmentation. All methods were performed
with the hardware and software specifications outlined in Table 1.
Table 1. Computational specifications for models implemented this project’s methods.
Computational Specifications
Hardware

Intel® Core™ i7-8565U CPU @ 1.80GHz × 8
16 GB RAM
2 TB Disk Space

Software

Ubuntu 18.04.3 LTS OS
PyCharm
Python 3.6.9
Keras 2.3.1 [27], Tensorflow 2.4.1 [26],
PANDAS, sklearn [17], matplotlib, seaborn,
numpy
JuPyteR

9

3.1 Dimensionality Reduction

When working with high-dimensional data, there are various phenomena that may affect
the result of our analysis; this is known as the curse of dimensionality. In order to avoid these
problems that may effect the model training and introduce noise in our classifiers, we will apply a
preprocessing step using Principal Component Analysis (PCA) or Linear Discriminant Analysis
(LDA). The main goal of applying dimensionality reduction (DR) is to reduce the dimensions
(features) of the data set by eliminating redundant and dependent information.
In PCA, the shape and location of the original data sets change when transformed to a
different space whereas LDA does not change the location but only tries to provide more class
separability and draw a decision region between the given classes. This method also helps to better
understand the distribution of the feature data.
Dimensionality reduction techniques are frequently applied to mitigate issues that arise
during analysis and training models with high-dimensional data. These methods offer a means of
denoising and simplification and can be beneficial for many modern biological datasets since it is
not uncommon for them to have the number of features measured per subject vastly exceed the
number of subjects in the study. Because of the “curse of dimensionality,” it is a common
experience to see rapid growth in the complexity of a problem and in the computational cost of
both training and prediction as the number of dimensions (features) increases. Thus, many
statistical and machine learning methods face challenges when applied to high-dimensional data.
One specific issue that arises with high dimensional datasets deals with the balance
between the size of the feature space and the number of samples collected. As the number of
features increases, the number of training samples needed to generalize a model increases
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incredibly. Thus, the smaller the sample size, the smaller feature space is needed to generalize a
model.
The high dimension of feature space also creates an issue in calculating the distance
between data samples, called distance concentration. That is, as the dimension of the feature space
for each sample increases, the distance between each sample tends towards a single value. Due to
distance concentration, the concept of proximity or similarity of the samples may not be
meaningful in higher dimensions. By reducing the dimensionality of the data, it is usually possible
to alleviate these challenging and troublesome phenomena. Low-dimensional data representations
that remove noise but retain the pertinent information can be instrumental in understanding hidden
structures and patterns in high dimensional microbiome profile data.
For continuous and count data, we apply preprocessing before applying DR. Appropriate
data preprocessing is often necessary. For example, centering the data and subtracting the mean of
each feature from each observation is a required step for PCA on continuous variables and is
applied by default in most standard implementations of the algorithm. Scaling is another
commonly applied data preprocessing step, where we multiply each measurement by a scalar so
that the resulting feature has a variance of one. This scaling transformation guarantees an equal
contribution from every feature, which is especially important when dealing with data that contains
diverse features with highly variable scales (clinical patient data).
However, when units of the features are the same, as we have in microbiome profile data,
normalizing feature variances is not needed since it would shrink values of features that contain
strong characteristics and inflate values of features with little information. Other data
preprocessing steps may be required, depending on the application, the type of input data, and the
DR method used.
11

Although many dimensionality reduction techniques exist. Principal Component Analysis
(PCA) and Linear Discriminant Analysis (LDA) are two commonly used techniques for data
classification and dimensionality reduction. Here we detail the methods and apply PCA and LDA
as dimensionality reduction methods, and later examine the effect in applying these methods to
the IBD microbiome profile data set as a preprocessing method before disease classification.

3.1.1 Principal Component Analysis

Principal component analysis is a technique frequently applied to reduce the dimension of
high dimensional datasets. Although the concept has been around since before the Second World
War, it was not until several decades ago that it became a popular method for feature selection and
dimensionality reduction [17]. The method works by finding the features with the most variance
across samples and projecting the original data samples into a new space, where each dimension
in the new space is called a principal component [18]. Each of these principal components is a
linear combination of uncorrelated original features, and the amount of information captured from
the original variables decreases consecutively with each principal component.
PCA is most commonly used to transform samples into a new space and use this lowerdimensional representation from the new space to denote the sample. The original data in the
original n-dimensional space is mapped to principal components in n-dimensional space. A small
number of principal components are chosen to represent the data, thus reducing the dimension of
the feature space while keeping a large percentage of the explained variance. We can determine
the amount of information we are willing to lose from dimensionality reduction by plotting the
percentage of explained variance for each principal component and summing the percentage for
each principal component (Figure 5).
12

Figure 4. This scree plot shows the percentage of explained variance for the top 20
principal components. The elbow method is used to determine an approximate cut off
point for the reduced dimension space.

Figure 5. This plot shows the cumulative percentage of explained variance for the top 20
principal components. We can use this in conjunction with the scree plot to determine
exactly what dimension space will result in an acceptable measure of information loss.

Plotting the percentage of explained variance for each principal component is called a scree
plot (Figure 4). This allows one to ascertain the number of principal components to use to represent
the data in the lower-dimensional subspace. Additionally, plotting the cumulative percentage of
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explained variance (Figure 5) as we include each additional principal component allows us to see
that we can reduce the dimension from 931 to 20, about a 97% decrease in feature space size, while
retaining 96% of the information from the original taxonomic microbiome profiles.
For the IBD microbiome profiles, we reduce the data to two and three dimensions
to analyze any obvious structure or separation across classes, non-IBD, ulcerative colitis, and
Crohn’s disease. We can see in Figure 6 that the two-dimensional representation of the IBD
microbiome profiles shows no obvious separation across classes. Similarly with the threedimensional representation shown in Figure 7, we see no clear evidence of separation across the
three classes, or across the binary classifications of disease (ulcerative colitis and Crohn’s disease)
and non-disease (non-IBD).
In this case, PCA seems to be an appropriate choice for visualization in a lower dimension
but might not offer the most predictive power. This may be due to the unsupervised nature of the
data, where variance is used in the data reduction, but the class labels are not incorporated, as we
will use in linear discriminant analysis. The final number of dimensions kept for input into the
classification models is chosen to be twenty.
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Figure 6. Visualization of the first two principal components generated from the IBD
microbiome profiles.

Figure 7. Visualization of the first three principal components generated from the IBD
microbiome profiles.
15

Dimensionality reduction via principal component analysis was considered as a
preprocessing step in microbiome profile classification. It was evaluated with the IBD microbiome
profiles and visualized in two and three dimensions. No visual separation was evident in the twoand three-dimension visualization of the first two and three principal components. This suggests
that using principal component analysis as an unsupervised method for preprocessing before
classification might be beneficial for excluding redundant information, but may offer no further
benefit in regards to mitigating issues with a relatively large feature space, which is expected since
class labels were not used in finding the optimal reduced dimension subspace. The suspected lack
of benefits compared to LDA will be presented later with the results of various classification
algorithms using the principal components as input.

3.1.2 Linear Discriminant Analysis

Linear discriminant analysis is another common technique used for dimensionality
reduction. Unlike PCA, it can use the class labels to train the model (but can also be unsupervised).
Its aim is to maximize the between-class variance and minimize the within-class variance,
effectively guaranteeing maximum separation across classes [18]. LDA is used for both
classification and as a preprocessing step in classification. For classification, decision boundaries
can be drawn between the maximally separated clusters of data points, to separate classes and
classify any new point into its class according to the given boundaries. As a means of
dimensionality reduction, the model parameters are trained on a set of training data to map the
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original data to a space whose size is one less than the number of classes. This can be used as a
lower dimensional representation, which may be beneficial in terms of separating classes and
mitigating the problems that arise with high dimensional input data. Because of this, we suspect
that using class labels to maximally separate the data and reduce it into a lower dimensional space
could provide an advantage over the unsupervised PCA method. We apply supervised LDA as a
dimensionality reduction technique in hopes of providing better classification in our classifiers.
When using LDA as a dimensionality reduction method, data sets can be transformed into
a reduced space in a class-dependent (supervised) or class-independent (unsupervised) fashion.
Here we use the class-dependent approach, the objective being to maximize the between class
variance, and minimize the within-class variance to obtain maximal separation between classes. In
other words, this will widen the space between classes and shrink the space within each cluster of
points of the same class.
Given a data set with K classes, with K ≥ 2, LDA allows us to find a hyperplane to project
our original data onto such that the interclass variance is minimized and the distance between the
projected means of the classes is maximized. To do this, a few assumptions are made. That is, we
assume that the density function of observations 𝑋 coming from the Kth class, 𝑓𝑘 (𝑋), is a normal
distribution with mean and variance parameters μ𝑘 and σ2𝑘 . It is also assumed that the variance
term for each of the K classes is the same, or σ12 = σ22 = … = σ2𝑘 . It is denoted by σ2 .
The hyperplane is obtained by solving an eigenvalue problem, with the corresponding
eigenvectors representing the desired hyperplane. Three steps need to be performed: calculating
the between-class variance, calculating the within-class variance, and constructing a new K-1
dimensional space. To calculate the between-class variance for a class 𝑖 ∈ 𝐾, the mean of the ith
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class (μ𝑖 ) and the global mean (μ) is calculated. To calculate the within-class variance for class
𝑖 ∈ 𝐾, the distance between the mean of the ith class (μ𝑖 ) and each of the samples in the ith class is
calculated. Once the between class variances and within class variances are calculated for each
class 𝑖 ∈ 𝐾, LDA works to minimize the distance between the class means projected into the new
space, and the samples projected into the new space.
Linear Discriminant Analysis (LDA) was proposed by R. Fischer in 1936 [19]. It consists
in finding the projection hyperplane that minimizes the interclass variance and maximizes the
distance between the projected means of the classes. Similar to PCA, these two objectives can be
solved by solving an eigenvalue problem with the corresponding eigenvector defining the
hyperplane of interest. This hyperplane can be used for classification, dimensionality reduction
and for interpretation of the importance of the given features.
This data dimensionality reduction method was applied to the IBD microbiome profile
dataset as a preprocessing step to separate the classes, get rid of unnecessary information, and
reduce the dimension. This makes the data easier to classify given the larger space between classes
and condensing of information, and mitigates the issues caused by using the high dimension dataset
in the machine learning classifiers. Figure 8 shows the two-dimensional LDA projection of the
microbiome profiles, colored by class. We see that the classes have little overlap after their
projection into the new space, hopefully making them more differentiable to our classifiers.
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Figure 8. Visualization of LDA-reduced taxonomic profiles for IBD patients.

The fact that PCA frequently results in good performance for feature identification and
LDA is more commonly presents good results for data classification or a preprocessing step to
data classification is evidenced by the clear separation of classes in the two-dimensional projection
from LDA compared to the two-dimensional projection from PCA. This simple projection using
LDA shows promise for using the microbiome profiles for classification of disease. In the next
sections, we will apply various machine learning algorithms to the reduced dimension data and
examine the results.
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3.2 Models

To classify microbiome samples as non-IBD, ulcerative colitis, or Crohn’s disease,
various machine learning models were trained such as Random Forest, Adaptive Boosting with
Decision Trees, Support Vector Machine, Light Gradient Boosting, K-Nearest Neighbors, Linear
Discriminant Analysis, and Multi-layer Perceptron. This section details the models that were used
for classification, with a brief description of how each model works. In all experiments, K-fold
cross validation is used to create a more well-rounded perspective of the actual model performance.
In K-fold cross validation, the data samples are randomly sampled without replacement into K
subsets of approximately equal size. The model is trained and evaluated k times, with one of the
subsets being used as a test set and the rest of the K-1 subsets being used as the training set. The
performance metrics resulting from each of the K model evaluations are averaged to produce a
single estimation for each performance measure. In this report, we use ten folds to evaluate the
accuracy, precision, recall, and area under the ROC curve as measures of algorithm performance.
After detailing the classification models, we discuss the use of generative models as a
method that shows potential for increasing classification performance by constructing an
augmented dataset. Ultimately, we train these models with reduced and augmented data to compare
the performance of the models for use in disease classification and detail the best results.
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3.2.1 Multi-Layer Perceptron
The multi-layer perceptron (MLP) model is a variation of the original Perceptron model
from 1950, which is a variant of a fully connected, feed-forward artificial neural network [20]. It
has an input layer, output layer, and one or multiple hidden layers in between connected by neurons
from each preceding layer. Initially it was applied as an alternative to statistical modeling
techniques, and has been used in a wide array of applications such as speech recognition [source],
atmospheric sciences [21], pattern recognition [22], engineering [23], and many others. It has even
been employed to model the spread of COVID-19 [24].
MLP is relatively easy to understand and implement and has been shown to give high
quality models with comparatively low training time in relation to more complex algorithms [24].
It works by feeding the input layer through what are initially random weights in the neural network
and adjusting them according to a loss function after a certain number of iterations through the
network, called an epoch. It first calculates the values of the neurons in each layer as a summation
of a linear combination of the outputs and their weights from the previous layer. The neurons are
then activated by the activation function for each layer, which allows one to put limits on the
neuron values or ignore them completely. By calculating the activated summation of weights and
neuron values for each layer and feeding those into each consecutive layer, it ends up with a result,
whose loss can be calculated by a specified function. The weights are adjusted proportionally to
the loss, such that at the end of iterating back and forth through the network, called
backpropagation, we are left with a set of trained weights that ends up minimizes the error.
MLP was used as one of the models to classify IBD microbiomes into disease classes. It
was implemented with the MLPClassifier from the python library sklearn, using common default
parameters (Table 3) [42]. The activation function was chosen to be rectified linear unit ('relu’);
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the solver for weight optimization was the ‘adam’ optimizer, which is based on the stochastic
gradient-descent method, and log-loss function was used to minimize error. The results of this can
be seen in the Results section.

3.2.2 Linear Discriminant Analysis

As mentioned in 3.1.2, LDA can be used as a classification algorithm in addition to a
dimensionality reduction method. After the data points have been projected into the lower
dimensional space that ensures maximal separation across data points from each class, a decision
boundary is constructed in this lower dimensional space. Recall that for K classes, the data is
mapped to a 𝐾 − 1 dimensional subspace. The decision boundary between any two classes 𝑖, 𝑗,
where 𝑖, 𝑗 ∈ 𝐾 corresponds to the line or hyperplane where

̂−𝜇
𝜇
𝑖 ̂𝑗
2

, the midpoint between the sample

means of the two classes [18].

3.2.3 K-Nearest Neighbors

K-Nearest Neighbors is a commonly used algorithm for classification due to its simplicity
in both its concept and implementation [18]. Its implementation has been proven to be valuable
for a wide array of applications, including those that use biological data. It has been trained to
solve problems ranging all the way from breast cancer classification [25] to predicting power
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output for wind farms [26]. Despite its simplicity, it has shown to perform well compared to other
machine learning classifiers in some contexts in various comparative studies [27].
The method works by using the “nearest” samples to estimate the conditional probability
for a sample being in a class given the values of the features in that sample. KNN then classifies
the sample to the class with the largest probability. In other words, a sample is classified to the
class that the majority of its neighbors are a part of. This method, although effective and simple,
is known to have some disadvantages like a large amount of computing for the classification of
each sample. This is because the distance, however that is defined, is calculated between each
unclassified sample and its K nearest neighbors, for every unclassified sample. The computational
complexity and time to classify also grows rapidly as the size of the feature space increases. For
that reason, we implement KNN on the lower-dimensional representation of the microbiome data,
as the original feature space may result in an impractically large amount of time to compute [18].

3.2.4 Adaptive Boosting

Adaptive Boosting is a general method aimed at improving predictive performance, usually
of decision trees [28]. It can be used on many machine learning models, but the default model
considered is decision trees. It works by combining the predictions from a variety of suboptimal
classifiers together to construct a stronger model, or one that shows higher predictive capability.
These suboptimal classifiers are called “weak” classifiers, because they classify better than random
chance, but still do not do an adequate job [18] [29]. Here, we use a decision tree as our weak
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classifier. Decision trees and adaptive boosting have both been shown to independently produce
satisfactory results for microbiome disease classification [7].
Adaptive Boosting first trains a “weak” model from the training data. The decision tree model
for classification works in two main steps:
1. Divide the feature space into J distinct, non-overlapping regions: 𝑅1 , 𝑅2 , … 𝑅𝑗
2. For each region, 𝑅𝑗 , assign the samples in that region to the most commonly occurring
class of training samples in that region.

Elaborating on step one, the distinct regions are chosen by dividing the feature space into highdimensional rectangles such that the choice of the rectangles minimizes the residual sum of
squares (RSS), given by

th
Where 𝑦̂
𝑅𝑗 is the average response for the training observations within the j rectangle. Because

this method is computationally infeasible, a method called recursive binary splitting is
implemented. This involves starting at the top decision stump and splitting the feature space into
two branches as it goes further down the tree. The best split (minimal RSS) is made at each stump,
and the process is repeated. Eventually, decision stump is constructed for each variable and
evaluated to gauge the performance of classifying the sample to its proper class.
After the first model is built, another model is trained with more focus on classifying the
samples that were classified incorrectly in the previous model. This is accomplished by weighting
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the samples based on the accuracy of the prediction from the previous model, so that the next
decision stump will classify those samples correctly. The process is repeated until either all the
samples have been properly classified or the specified maximum iterations have been computed.
There are three core hyperparameters that can be adjusted for this algorithm: the number
of trees, the learning rate, and the number of splits in each tree. Because boosting works off an
ensemble of decision tree models to determine the output, if the number of trees is too large the
model can be prone to overfitting. The learning rate is usually chosen to be a small number, and
for our analysis it’s chosen as .01, a default in most machine learning modeling libraries. The
number of splits in each tree controls the complexity of the final model. For boosting, it’s suggested
to have each tree consist of a single split. This means that for each step in the model building
process considers only a single predictor. This is called an additive model. This model has also
been used in various microbiome classification studies with various success rates and is considered
in our analysis [7].

3.2.5 Random Forest

The Random Forest algorithm provides an improvement to bootstrap aggregated (bagged)
decision tree algorithm. Recall that bootstrapping is the process of randomly selecting a number
of data points from the dataset, with replacement, and creating a number of new data sets. Bagging
provides an improvement on the classical decision tree algorithm by using many training sets from
the original data set, building a separate model on each training set, and averaging the predictions.
This reduces the variance of the model [18].
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Random Forest provides an improvement to bootstrap-aggregated decision trees by
allowing us to decorrelate the trees. A restriction is placed in random forest such that when
calculating the best predictor and predictor value at a decision stump, only a random sample of
predictors is chosen as split candidates, rather than all predictors. Generally, the square root of the
total number of predictors is chosen as the number of predictors to consider when making a split.
Predictions from bootstrap-aggregated trees are usually correlated, because the trees will use the
strongest predictor variable as the first split since this will produce the best RSS. This random
selection of predictors allows the trees to become decorrelated by giving them more likelihood to
consider other predictors and thus models that produce potentially different results [18]
The Random Forest algorithm has been used with good predictive capability on
microbiome data sets before [7]. Pasolli et al trained and tested Random Forest on various
microbiome datasets for the classification task and achieved AUCs from .66 to .95. Thus, the
random forest model is considered in our analysis.

3.2.6 LightBGM
LightGBM is another popular machine learning model based on decision trees. This model
is an extension of the Gradient Boosting Decision Tree algorithm [30]. Its implementation contains
two techniques to improve upon the Gradient Boosting Decision Tree (GBDT) algorithm, which
itself is an improvement of the Adaptive Boosting Decision Tree (AdaBoost) algorithm.
Recall that the GBDT method works to improve upon the boosting decision tree algorithm.
The original GBDT algorithm is a powerful machine learning technique that has been applied to
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various applications on many challenging problems. It works by building decision trees
sequentially such that the successive trees fit the residual of the previous trees. Given training data

And their labels

where y belongs to UC, CD, or non-IBD, the GBDT algorithm will construct a function that
minimizes the sum of the consecutive loss functions at each step. The loss function, defined by:

given that T is the number of iterations. To elaborate, the fm is the function that minimizes the
aggregated loss at step m, as the previous functions are kept static. For each iteration, the loss
function is defined as:

(1)

where

and
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GBDT chooses fm such that the right-hand side of equation (1) is minimized. The learning rate is
applied to fm before adding to to Fm-1. The advantage of GBDT is that the only part of the method
that changes for varying loss functions is the gradient, thus making the rest of the algorithm the
same [31].

LightGBM addresses both efficiency and scalability issues that happen with
GBDT when the sample size or the feature space is large. This is done through the introduction
of two techniques: gradient one-sided sampling, and exclusive feature bundling.

Gradient one-sided sampling (GOSS) is a technique that keeps the data that have a large
gradient (lots to learn from) and does not consider those with a small gradient when down sampling
data instances. More specifically, instead of discarding instances with a small gradient, which
would change the data distribution and lower accuracy in the test set, GOSS technique proposes
to keep all the instances with large gradients and randomly sample from the instances with small
gradients. This solution offers a similar accuracy while providing a smaller computation cost.
The second technique implemented in LightGBM is called exclusive feature bundling
(EFB). As its name implies, it allows us to reduce the number of features that are being looked at
for tree splits by bundling features. This allows the computational complexity to go from
O(number samples × number features) to O(number samples × number feature bundles) where the
number of feature bundles is much less than that number of features [30].These two approaches
combined allow LightGBM to effectively deal with both a large feature space and a large number
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of samples, two issues in GBDT that caused the algorithm to be unusable for large data sets due to
computational complexity. Our analysis implements LightGBM as a classification technique.

3.2.7 Support Vector Machine

The Support Vector Machine (SVM) algorithm has been a popular choice for classification
models in the past decade. It addresses the problem of possible non-linear decision boundaries
between classes by enlarging the feature space using functions of the predictors and the predictors
themselves. In the enlarged feature space, the decision boundary is linear, and can be efficiently
used as a classification model [18].

Enlarging the feature space is implemented with something called kernels, which
is a function that allows us to measure the similarity between points. Using a high order
polynomial function as a kernel allows the algorithm to fit a classifier in a higher dimensional
space rather than the original feature space. In our analysis, we use the radial bias function, or
RBF, as the kernel.

SVM has been used with good predictive capability on microbiome data sets
before [7]. In a review of microbiome classification models, Pasolli et al. showed that using
SVM on various microbiome data sets achieved an ROC AUC from .66 to .92 in several
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classification tasks [32]. The results of this algorithm applied to our data set and the VAEaugmented data set are detailed in later sections.

3.3 Generative Models

While dimensionality reduction on microbiome profiles denoises and simplifies our data,
augmenting the data set by using deep generative models to create synthetic microbiome profiles
is a promising method that offers potential to increase model performance. Data generation is a
fundamental problem in many areas of artificial intelligence such as computer vision pattern
recognition, detecting anomalies, synthesizing transient light curves, drawing images, as well as
biological research [33-36]. In recent years, deep generative models have gained increased
attention due to their success in numerous applications such as deep-fake identification [37],
missing data imputation [38], anomaly detection [39], recommender systems [40] and many more.
Among deep generative models, variational autoencoders (VAE) are regarded as one of the most
popular approaches to generative modeling in biomedical and engineering applications [41]. Data
generation is an important problem in the task of using microbiome profiles to classify disease due
to the prevalence of a large feature space relative to sample sizes. The use of deep generative
models in the microbiome host trait prediction problem enables the use of larger sample sizes in
training classification models. They also offer a potential solution to the common problem of
imbalanced class sizes. By generating samples only for specific classes, the class distribution may
become more balanced. Having balanced class sizes gives the model a better idea of the true data
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representation per class and allows it to focus on learning the defining characteristics of each class
equally [42]. Using VAE to generate synthetic data may help to mitigate the issues that arise from
each of these issues, thus improving classification performance.

Here we construct and apply a VAE to generate artificial microbiome profiles for
each class, then add them to the data set in a way that balances the samples per class, and
examine any changes in performance of our classification models. We use the best-performing
method from the baseline machine learning models, LightGBM with original size microbiome
profile input, as a method for which to compare results.

3.3.1 Variational Autoencoder Model

Variational autoencoders were introduced in 2014 and provide a framework for deep
generative models (DGM), which have demonstrated themselves as an effective deep learning
architecture for semi-supervised and unsupervised learning [43] [44] [45]. Included in this section
is an explanation of using the VAE for data augmentation. The process for using synthetic
microbiome profiles to improve classification involves several steps: training the VAE to generate
accurate synthetic microbiome profiles, generating synthetic microbiome profiles, and using the
artificial and original microbiome profiles to train a set of baseline classifiers. Before we dive into
the details of that process, a brief explanation of the VAE will be given.

The variational autoencoder is a type of deep generative model that learns latent
representations by modeling a data distribution from a collection of independent latent variables
[43]. It is a variant of the standard autoencoder model that allows one to generate data based on a
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set of training data. Similar to the standard autoencoder framework, the VAE involves two
connected neural networks that support each other. The VAE can be viewed as two linked, but
independently parameterized models: the encoder model and the decoder model. The encoder
model acts as the recognition model, and the decoder acts as the generative model.

The process of training the VAE and generating samples involves encoding the
observed samples, in this case microbiome profiles, denoted x, as a distribution in the bottleneck
space of latent variables, denoted z. The encoder part of the VAE framework acts as an inference
model by learning the distribution over the possible values of the latent variables from which the
data point could have been generated. Specifically, it learns the latent space distribution
parameters, denoted θ, that define this distribution in an optimal way. A point from the latent
space is then sampled from that distribution, where the decoder works to reconstruct the smalldimensional latent variable to the 933-dimensional microbiome profile, and the loss is computed.

To find the distribution of the latent space, denoted pθ(z|x), the prior, pθ(z),
likelihood, pθ(x|z), and postieror, pθ(z|x) are used. Once the optimal pθ is obtained, we can then
generate a sample that resembles a real data point, xi¸by sampling a latent variable, zi, from the
optimal prior distribution, pθ(z), and generating xi from the optimal conditional distribution,

pθ∗(x | z = zi)
Generally, the optimal parameter, θ*, is the one that maximizes the probability of
generating real data samples, which can be found through
pθ(xi) = ∫ pθ(xi | z) pθ(z) dz
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However, there is a problem with the above goal under certain common conditions, namely that
pθ(xi) is often intractable and that large data sets impose a large computational burden in the
process. Thus, the authors of the VAE introduce an approximation to finding the intractable true
posterior, pθ(z|x), so we can output what is a likely latent variable z given an input x: qϕ(z | x),
parametrized by ϕ. The problem then becomes finding an approximation to the true posterior that
is as close as possible to the true latent distribution (Figure 9).

Figure 9. This diagram displays the relationship between the unknown, but real, hidden universe
of processes in read (true latent distribution), versus the optimal tractable approximation of the
true distribution in purple.

Finding an optimal approximate distribution, qϕ , is done by minimizing its
distance to the true distribution. A method to quantify distance between two distributions is
through Kullback-Leibler Divergence, commonly referred to as KL-Divergence. This method
allows us to measure the information loss when using our distribution qϕ to represent another
distribution pθ.

Ultimately, VAEs combine the KL-Divergence measure along with reconstruction
error in the loss function in order to optimize the parameters ϕ that result in the best performing
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VAE. The loss function that is minimized during training is composed of a “reconstruction
term”, which makes the encoding-decoding process as accurate as possible, and a “regularization
term”, which acts to regularize the latent space by making the distributions returned by the
encoder approximately standard normal distribution:

where DKL( qϕ(z|x) ∥ pθ(z|x) ) is the KL-Divergence measure between approximate and true
posteriors, 𝑞 and 𝑝, and the second term is the reconstruction loss.

In other words, the error that is minimized when training the VAE involves
minimizing the difference between the approximated latent variable distribution and the true
latent variable distribution (KL-Divergence regularization), as well as minimizing the
reconstruction loss between input and output. In Variational Bayesian methods, the loss function
here is also referred so as the evidence lower bound (ELBO). An overview of the process is
shown in Figure 10 below.
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Figure 10. Adapted from [43], this diagram shows a high level overview of the VAE architecture,
which involves encoding the observed data into a latent space, decoding it, calculating the loss and
repeatedly adjusting the network parameters.

In addition to the standard variational autoencoder, several other variations exist.
One such variation, named the β-VAE, proposes adjusting the loss function to focus more on the
regularization term as the network is trained [45]. This is done by introducing a scalar, β, to
multiply the KL-Divergence term by in the loss function. This method is also experimented with
in this work, with a β value of two (doubling the focus on the regularization of the latent space).

In practice, constructing the VAE was done using tensorflow and keras python
libraries [46, 47]. The VAE was trained over 150 epochs, with other hyperparameters shown in
Table 2. Tensorboard was used to visualize the loss over epochs and ensure training and test loss
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decrease with time and remained steady. An overview of the VAE architecture trained and
utilized to generate artificial microbiome samples in practice is shown in Figure 11.

Figure 11. Diagram shows the VAE model architecture used for this work, along with a
visualization how of the synthetic data are generated. Blue scatterplot and distributions show the
2D Latent space distribution for the VAE training data while the purple dots show the grid of
values used to generate new samples.
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Table 2. Hyperparameters and their chosen values for VAE and β -VAE models.

Algorithm
VAE

β-VAE

Hyperparameters for VAE Models
Parameter Name
Parameter Value
epochs
150
batch size
16
encoding dimension
2
learning rate
0.001
Activation function
Relu
β
2
epochs
150
batch size
16
encoding dimension
2
learning rate
0.001
Activation function
Relu

4 Results
In this section, the results obtained from the computational experiments discussed
previously are presented. To measure the applicability of VAE data augmentation on a set of
baseline machine learning classifiers, the results from the baseline models are compared against
the same models trained with an added 50% and 100% additional data. The baseline models are
trained with the original IBD microbiome profile dataset from iHMP and classify microbiome
samples as ulcerative colitis, Crohn’s disease, or non-IBD. The performance of the classifiers on
multiclass disease classification using microbiome profiles is measured by calculating, accuracy,
precision, recall, and F1 score with 10-fold cross validation.
Applying our various machine learning models to reduced-dimension microbiome profiles
has shown several of them to be very successful when measuring performance as noted above.
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However, in this thesis we look to improve upon the accuracy of these classifiers by creating a
larger sample size and evening out class imbalances with a generative deep learning model to
construct synthetic microbiome profiles. Below, we will discuss the results of applying the
machine learning and deep learning algorithms examined in Section 3 to the microbiome profiles
of individuals with Crohn’s disease, ulcerative colitis, or no IBD. We present these findings in this
section in the hope that they can be extended to other real-world microbiome profile data to
ultimately create high accuracy diagnostic testing for diseases with unknown etiology whose
diagnostic procedure is a diagnosis of exclusion or nonexistent and eventually used by clinicians
to accurately diagnose and help direct treatment.

4.1 Results of Baseline Models

In analyzing the microbiome profiles of healthy and IBD-diagnosed individuals,
we constructed a lower-dimensional representation of these profiles using two methods:
Principle Component Analysis (PCA) and Linear Discriminant Analysis (LDA). Each set of
representations serves as input to the classification algorithms discussed in Section 3, namely
Multi-layer Perceptron, Linear Discriminant Analysis, K-Nearest Neighbors, Adaptive Boosting
with Decision Trees, Random Forest, LightGBM, and Support Vector Machine. All the
computations were done with the software Python. Computational specifications are listed in
Table 1.

The PCA and LDA reduced-dimension representations of the microbiome profiles
were developed with the Python “sklearn” package [48]. For more in-depth information about
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the mathematics of constructing reduced representations of our input via PCA and LDA, see
Section 3. Our microbiome profiles contain 933 features. First, we used PCA to generate 933
principal components. The optimal number of principal components to use in our input
representations was chosen by determining an acceptable level of information loss after looking
at plot of cumulative explained variance for the principal components (Figure 5). The calculated
information loss from using twenty principal components to represent our input data was only
4% (shown in Figure 4), while reducing the dimension by 97.8%, from 933 to 20, so twenty was
chosen as the number of components to represent the data. LDA was also chosen as a
preprocessing method to reduce the dimension of the microbiome profiles before inputting them
into classification algorithms. As mentioned in Section 3, the size of the reduced dimension
space for LDA is one less than the number of classes, which in our case was three. Thus, the size
of the reduced dimension representation using LDA is two, giving a 99.7% reduction in feature
space. The two- and three-dimensional visualizations for the microbiome data, as well as a
discussion of the details of PCA and LDA can be seen in Section 3.

Once the microbiome profile feature space reduction was completed, the reduceddimension representations and the original data set were used as input into an array of classifiers
to determine how well the models can successfully differentiate between non-IBD, Crohn’s
disease, and ulcerative colitis patients. The hyperparameters for each algorithm were chosen by
varying the parameter within a reasonable range and choosing the parameter that produced the best
accuracy. This was programmatically achieved by using the GridSearch functionality in the sklearn
Python library [48]. The parameters for each baseline algorithm are detailed in Table 3.
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Table 3. Hyperparameters chosen for each machine learning algorithm that differ from
the default in each package or need to be specified.
Hyperparameters for Baseline Models
Algorithm
LightGBM

RF
MLP
SVM
AdaBoost
KNN
LDA

Parameter Name
max_depth
num_leaves
learning_rate
num_iterations
n_estimators
max_depth
activation
learning_rate
C
kernel
base_estimator
K
n_components

Parameter Value
15
215
0.1
250
200
7
Tanh
Adaptive
0.025
RBF
DescisionTreeClassifier
3
2

The results from these models are used as a basis for comparison against the
results from the augmented models in the following section. A multi-class classification model
for each of the models was constructed using “sklearn,” with the exception of LightGBM which
uses the python library “lightgbm” [49]. In each model, the results are evaluated using K-Fold
cross validation with ten folds. For each of the K “folds,” or partitions, the data is trained on the
K-1 remaining partitions and tested on one holdout partition. The training data is used to train the
LDA or PCA model for dimensionality reduction as well as the machine learning classifier. Then
the test data is reduced using that dimensionality reduction model and predictions are made on
the test set. The performance metrics of accuracy, precision, recall, F1 and AUC are averaged
across the folds for each algorithm to produce a more accurate representation of each model's
performance. Table 4 provides details on the average accuracy and AUC across the ten folds for
each model with the PCA inputs, LDA inputs, and the original data inputs. The area under the
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ROC curve (AUC) was calculated in a one-vs-rest fashion. The highest test AUC and accuracy
obtained with various inputs across the models is highlighted.

Table 4. Accuracy and one-vs-rest AUC were calculated and averaged for every model
across ten folds. Models used the non-augmented data set with 1638 samples and 1422
features. Each model was trained and tested with a twenty-dimension PCA input, and
two- dimension LDA input, and original data input.
Results from Multiclass Baseline Models
Algorithm

LightGBM
RF
MLP
SVM
AdaBoost
KNN
LDA

Average
Accuracy,
20-PCA
input (%)
75.3
66.9
70.8
49.0
54.8
61.2
49.4

Average
AUC, 20PCA
input (%)
88.7
83.8
84.8
66.0
66.0
77.8
67.7

Average
Accuracy
, LDA
input (%)
73.1
74.5
74.8
74.2
66.8
74.5
74.0

Average
AUC,
LDA
input (%)
84.7
85.0
83.3
83.2
77.0
85.0
83.2

Average
Accuracy,
Original
data (%)
94.6
84.0
90.4
75.4
72.8
68.0
73.9

Average
AUC,
Original
data (%)
98.8
95.9
95.8
88.7
84.4
83.7
83.3

Table 5. Accuracy and AUC were calculated and averaged for every model across ten
folds. Models used the non-augmented data set with 1638 samples and 1422 features to
classify diseased vs healthy. Each model was trained with original data input.
Algorithm

LightGBM
RF
MLP
SVM
AdaBoost
KNN
LDA

Results from Binary Baseline Models
Average
Average AUC,
Accuracy,
Original data (%)
Original data (%)
96.4
99.0
89.8
96.2
95.0
96.9
85.4
90.4
89.7
93.5
82.8
85.8
83.3
85.7
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Other measures of performance such as F1-score, precision, and recall are shown in more
detail in Figure 12. Here we see the performance metrics broken down per class and per inputtype. This visual allows us to see a somewhat uniform distribution of performance measures across
classes for most models.
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Figure 12A. Class-wise baseline algorithm performance metrics for PCA and LDA-reduced inputs.

Figure 13B. Plots show the algorithm performance metrics averaged across ten folds and
partitioned by class for all models. The models used the first twenty principal components and 2d
LDA
representations
as
the
lower
dimensional
input.
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The performance metrics in the above figures and table confirm that the
microbiome profiles contain information that allow us to differentiate between classes of nonIBD, Crohn’s disease, and ulcerative colitis. Using original microbiome data representations
proved to be the most effective input to achieve the highest scoring classifiers, both in accuracy
and AUC measures. The results of these baseline methods are in line with similar methods
executed on similar microbiome profile data sets in other studies without biological data [13]
[14] [15]. Baseline model performance with only original data input is also visualized below in
Figure 13 and detailed in Table 4. As evidenced by the bar plot, LightGBM achieved the highest
scores across multiple measures of performance, while SVM achieves the worst performance.

Figure 14. Average model accuracy across various baseline models on microbiome data.
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A weakness in models trained with the reduced dimension input is made evident in
the lower accuracy and AUC scores for all models compared to those trained with the original
data as input. Figure 14 compares the average accuracy and AUC scores when training and
testing the multiclass classification with various reduced inputs.

Figure 15. Average ten-fold model accuracy (top) and one-vs-rest AUC (bottom) for
PCA-reduced, LCA-reduced, and original size dataset demonstrates generally higher
performance for models trained on non-reduced data.

This may indicate that the original microbiome profiles contain complex
relationships, some of which are lost in the dimension reduction with PCA and LDA. Even
though using the top twenty principal components resulted in only a 4% information loss, the
accuracy and AUC of the result compared to that of the models trained with the original data
demonstrates the complexity of the relationships between different taxa in the microbiome.
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4.2 Results from Augmented Models

Traditional machine learning models examined thus far provide moderately wellperforming classification models for disease prediction. Nevertheless, in order for clinicians to
gain confidence in leveraging classification models for disease diagnosis, it is imperative that the
classification models used to predict disease are as accurate as possible, while maintaining
generalizability. Variational autoencoders for data augmentation and class balancing provide a
promising avenue to construct higher accuracy classification models for disease prediction.
To achieve this, a variational autoencoder (VAE) model is trained on the original
dimension dataset. To provide more samples and improve class imbalances, microbiome profiles
are generated for the two classes with the least samples, non-IBD and ulcerative colitis.
This VAE model was developed with the python package “tensorflow” [46]. The model
construction involved two networks, as mentioned in Section 3.3.1. The encoder network involves
several fully connected (“Dense”) layers that connect to the two-dimensional latent space and
sampling layer. The decoder network involves several fully connected (“Dense”) layers that
reconstruct the latent variables to their microbiome profile form. Two types of VAEs were
examined, VAE and β-VAE. The difference between the two is the loss function that is used to
optimize the encoder and decoder networks. A more detailed explanation of the two architectures
can be seen in Section 3.3.1.
In order to generate samples, the VAE was trained on non-IBD, Crohn’s, and ulcerative
colitis microbiome profiles, and then several hundred vectors whose size and range correspond to
that of the latent space were fed into the sampling layer and reconstructed with the decoding
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network to form the synthetic microbiome profiles for each class. Figure 10 from Section 3.3.1
displays a high-level overview of the architecture used for the VAE. A summary of the VAE model
layers is provided in Figure 11.
Once this process is finished, the synthetic microbiome profiles generated in these classes
were added to the original dataset in the needed percentage for class balancing and the
dimensionality reduction and classification were performed as they were in section 4.1. The
distribution of class labels in the augmented dataset is shown below in Figure 15.

Figure 16. Distribution of the VAE-augmented microbiome profile dataset shows more
samples and a less imbalanced distribution of samples across classes.

Since the dimensionality reduction preprocessing techniques examined earlier produced
lower accuracy than classifiers trained with the original data, the lower-dimension representations
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of the microbiome profiles produced from LDA and PCA are not used for the data augmentation
comparison. Instead, the original input is fed into the previously detailed machine learning models
as a basis for comparison against those models trained with the original-dimension augmented and
class-balanced dataset. The resulting classification metrics of accuracy, precision, recall, F1 and
one-vs-rest AUC are shown in Table 6 below. LightGBM achieved the highest accuracy, at 97.5%,
when adding 100% more data to the data set. This score slightly surpasses the highest classification
accuracy and AUC in similar studies that used microbiome profile data to predict host disease.

Table 6. Accuracy and one-vs-rest AUC were calculated and averaged for every model
across ten folds. Models used the augmented data set with an additional 100% samples
and 933 taxa features. Each model was trained and tested with a twenty-dimension PCA
input, and original data input.
Results from Multiclass Augmented Models
Algorithm

Average
Accuracy,
20-PCA
input (%)

Average
AUC, 20PCA
input (%)

Average
Accuracy,
LDA
input (%)

Average
AUC,
LDA
input (%)

Average
Accuracy,
Original
data (%)

Average
AUC,
Original
data (%)

69.5

85.4

85

86.4

86.1

91.8

LDA

43.6

67.3

88.3

92.2

88.5

92.6

LightGBM

88.7

97.8

87.2

95.2

97.5

99.8

MLP

50.7

73.4

88.2

93.3

93.9

97.7

Nearest
Neighbors

84.1

88.1

86.8

90.1

89.2

91.9

RBF SVM

56.9

75.4

87.7

94.5

60.1

81

Random Forest 84.7

96.6

88

94.5

79.4

98.3

AdaBoost
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A graphical representation of the results of the data augmentation is also provided in Figure
16. This plot demonstrates that adding more augmented data increases the multiclass classification
accuracy substantially. Results indicate that the performance across almost all models and classes
was improved by augmenting and balancing the data set with VAE-generated microbiome profiles,
and that additional data gives additional accuracy. Average accuracy scores increased when
comparing baseline model to added 50% augmented model, and again when comparing 50%
augmented models to 100% augmented models.

Figure 17. Performance metrics for VAE-augmented and class-balanced microbiome
profile dataset shows improvements in accuracy in classifying non-IBD, Crohn’s and
ulcerative colitis across all classification algorithms.

Additionally, in order to create a more accurate comparison to other work, as we will
examine in the following section, the baseline binary classification models were also compared
against augmented binary classification models. Results were similar, and LightGBM again
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achieved the highest classification scores, as shown in the confusion matrix plot below (Figure
17).

Figure 18. Confusion matrix for LightGBM, the best performing augmented binary
classification model shows only three misclassified samples in the test set. With an
average accuracy of 97.6% and AUC of .996, this binary classification result surpasses
classification problems.
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4.2.1 Variations of Variational Autoencoder

The VAE-augmented data shows promising results for increasing classification
accuracy for multiclass and binary disease classification models with microbiome profiles.
However, several variations of the VAE architecture exist that should be explored. One such
architecture, the β-VAE was also implemented and compared to the initial VAE results. As
discussed in Section 3.3.1, the β-VAE puts more weight on the regularization term in the loss
function. This architecture was also implemented in a similar fashion as the initial VAE
architecture described above. The hyperparameters for the β-VAE model are shown in Table 2.

Figure 19. Average ten-fold model accuracy for models with original data set, original
data set plus 100% more VAE-generated data, and original data set plus 100% more
βVAE-generated data.
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The data augmentation for the β-VAE was accomplished in a similar fashion to the VAE
data augmentation, and is compared to the results of the 100% VAE-augmented models in Figure
X above. The β-VAE augmentation with 100% additional data shows a similar boost in
performance across classifiers as the VAE implementation. The worst performing model, SVM,
notably obtained a large accuracy increase by using the β-VAE architecture rather than the initial
VAE architecture.

5 Significance and Future Work
In this work we studied the effect of applying a state-of-the-art deep generative data
augmentation technique in the microbiome host disease prediction problem. Classifying disease
with microbiome profile data is a challenging problem due to both the number of instances per
class being unbalanced, and the small sample size that often present themselves in this domain.
There are several studies that demonstrate both the success of classifying different microbiome
data sets into disease classes, as well as the effectiveness of applying deep generative models to
augment the data set, but to our knowledge no previous studies have demonstrated the effect of
applying VAE in the microbiome disease classification problem. In this work we applied two types
of VAE models for generating augmented data and introduced modifications to the original class
distribution to both increase the sample size and balance classes. The resulting methods showed a
substantial increase in classification accuracy, bringing our best model, LightGBM, from 94.7%
average accuracy to 97.5% average accuracy for non-augmented vs augmented training sets. The
results shown in Table 6 and Figure 16 are the most important results of this work, as they
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demonstrate that an increase in accuracy can be obtained for various models by adding additional
synthetic microbiome samples in a class-balancing fashion.
This increased accuracy in disease classification with microbiome profiles can be important
in demonstrating their potential use as an accurate proxy in diagnostic testing. In cases where
established diagnosis tests are more expensive, complex, or time-consuming compared to
obtaining a microbiome profile, disease classification models can provide information to help
clinicians make decisions about diagnosis and treatment options. Future work should involve
generalizing this method to other microbiome datasets to confirm usefulness across data sets and
sizes, examining variations in architectures as a means of further improving performance. Another
follow on that could illuminate the important taxa in the microbiome profile that change with
disease diagnosis would involve examining the latent space of the VAE encoder to extrapolate the
complex relationships between input variables (taxa relative abundance) and examining the effect
of varying the value of the latent variables on data point’s disease subtype or class. Additionally,
examining the dimensionality reduction techniques with more manual feature selection techniques
implement beforehand could be an additional avenue to explore.
Practical applications for this work that serve as both potential future work and emphasize
the importance of results include integrating best performing models into computer systems that
clinicians have access to. Once further verification of the models across different data sets has
been accomplished, using the model to classify diseased patients into the corresponding classes
could provide an input to practitioners where otherwise there may be a diagnosis of exclusion or
no diagnostic testing. This is important for improving quality of life of many individuals who
suffer from the debilitating symptoms of diseases like IBD and can act as a framework for allowing
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clinicians to identify diseases other conditions or diseases with unknown etiology that are
associated with the microbiome.

6 Related Work
To our knowledge, this thesis presents the first effort towards using VAE data
augmentation for improving microbiome host disease prediction. However, existing efforts
examine the predictive capabilities of machine learning classifiers on IBD microbiome profiles
with similar methods [12, 13, 14, 15]. Studies used varying data sets, methods, and performance
metrics for the IBD microbiome classification problem. Various sample sizes were also present,
although all were considered small data set sizes (Table 7).
A summary of the results from several recent studies are listed in Table 7. The most similar
study to this work was carried out by Lo & Marculescu, who used a variety of deep learning
techniques with a data augmentation method on the iHMP IBD microbiome data set, as well as
other data sets [14]. The data augmentation method involved fitting the parameters of a negative
binomial distribution to model the microbiome profiles and sampling this optimal distribution to
generate augmented data samples. MLP and convolutional neural networks were used as
classification models on the augmented dataset and compared. Their comparison metric was F1micro and F1-macro, which showed that using the augmented dataset on the IBD microbiome
profiles with MLP boosted the F1-micro from .82 to .84. Our study differentiates itself from
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previous work in that we let the VAE determine the latent distribution and generate the augmented
samples via this learned distribution. The advantage to using VAEs for the data augmentation is
that we didn’t have to define a distribution or explicitly model the generative process, other than
forcing the latent space to be Gaussian.
Other similar studies listed in the table below also performed microbiome disease
classification with an IBD microbiome data set. Results indicate that our work accomplishes the
highest scores for average accuracy, average precision, average AUC and average F1-micro when
compared to the recent relevant works. Even when comparing these studies to the non-augmented
baseline model results for disease classification shown in Table 7, the scores surpass those of the
known relevant studies.

55

Table 7. Summary of benchmark datasets mentioned in Section 1. AP indicates average
precision, AA average accuracy and AAUC average AUC.
Results from Benchmark Models
Benchmark
Paper

Number
Samples

OTUs

Number
Classes

Best
AP
(%)

Best
AA
(%)

Best
AAUC
(%)

Best
Avg.
F1micro

Best
Algorithm

MLP+
Dropout +
NBAugmentation

Data
Source

Lo &
Marculescu

1025

1025

2

-

-

-

.84

Xu et al

349

2661

2

96.3

-

96.8

-

LightGBM

Privately
Owned

Hacilar et
al

382

1455

2

-

91.6

93.3

.89

KMeans +
LogitBoost

MetaHit

This
Project

1168*2

933

3

97.5

97.5

99.7

.974

LightGBM +
VAEAugmentation

iHMP

This
Project

1168*2

933

2

97.8

97.6

99.7

.971

LightGBM +
VAEAugmentation

iHMP

iHMP

Previous work involving using classification algorithms with microbiome profiles to
classify disease has resulted in AUCs ranging from 93.3 to 96.8 [12, 13]. The small sample size
compared to large number of features in the microbiome taxonomy profiles and frequent class
imbalance may lead to lower AUC scores in classification. Part of the reason for using VAE to
augment the microbiome disease classifiers was to alleviate the problem of small sample size
compared to feature space, and class imbalances, which may account for the difference in scoring
between our results and those of similar studies. Although there is no one-to-one direct comparison
to previous work, the results of the methods and experiments produced in comparing baseline to
augmented model results provide an insight into the viability of using deep generative models to
improve the classification performance of disease classification models with IBD microbiome
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profiles. Comparing to previous relevant studies only serves to confirm the hypothesis that the
methods presented in this work are capable of producing highly accurate multiclass and binary
disease classification models.

7 Conclusion
Given the increasing amount of biological data being collected, and the number of people
suffering from debilitating diseases like IBD, using classification models as a proxy for diagnosis
or input to the clinician in helping aid diagnosis and treatment is becoming a more viable option.
In this work, we proposed using deep generative models as a strategy to leverage existing
microbiome data to improve host disease classification performance. We examined the effect of
implementing a state-of-the-art deep generative model for data augmentation in the context of
disease classification with a small and unbalanced biological data set of patient microbiome
profiles. Data sets with small sample size, large feature space, and unbalanced classes are
frequently encountered within biological applications, and improving said characteristics
artificially when past study designs and limitations placed restrictions on the data collect gives
improved performance for classification algorithms trained on such data.
We applied two types of the variational autoencoder model for the generation of artificial
microbiome profile data, and generated samples such that the augmented sample class distribution
is almost perfectly balanced between three classes. A set of machine learning classifiers were used
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as a baseline to quantify the performance of using artificial data in conjunction with the original
data in classifying samples into three subtypes of a disease called inflammatory bowel disease
(IBD): ulcerative colitis, Crohn’s disease, and non-IBD. The results shown in Table 6, together
with those shown in Table 7 suggest that using VAEs to augment biological data sets can improve
multiclass classification model performance via improving class imbalances, enlarging the sample
size, and improving the feature to sample size ratio. The best results were obtained when the
baseline classifier used was LightGBM, and the size of the augmented data set was the same size
as the original data, rather than half the size. The result of this work shows that data augmentation
for microbiome-disease classification increases average prediction accuracy for many types of
machine learning models, and consistently outperforms models trained on the smaller original data
set. Implementing traditional dimensionality reduction techniques like PCA and LDA before
training the classifiers resulted in an average net decrease in performance accuracy and AUC,
suggesting that relationships among features (OTUs) within the microbiome profiles are complex
and which supports the belief that fully understanding the functional aspects and cause and effect
of taxa abundances within the microbiome is a challenging task [11]. Additionally, sampling the
VAE latent space in various fashions when generating artificial data showed no significant
difference in performance scores among models. Additional VAE architectures like β-VAE or
Info-VAE, as well as the relationship between latent space values and the resulting sample
characteristics could be examined going forward to gain a better understanding of how to optimally
implement deep generative models in this context.
Ultimately, we demonstrated that using the VAE framework to augment training data for
machine learning classifiers in the microbiome-disease classification task gives increased
performance in a number of models across several performance metrics. The application of VAEs
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to microbiome disease prediction has not been implemented before, but performance scores of
average accuracy, precision, F1, and AUC appeared higher than other similar studies and baseline
models. This work suggests that generating synthetic microbiome profiles VAEs is a viable
method for improving microbiome disease classification models, and implicates deep generative
models in conjunction with machine learning models as a potential resource for disease
diagnostics. Using this artificial data with baseline machine learning models to create novel
diagnostic tools for diseases with unknown etiology can be helpful for clinicians where disease
diagnostic criteria are not well defined or involve a diagnosis of exclusion and improve the lives
of people who are suffering from hard to diagnose diseases.
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